[Script Info]
Title: 
[Events]
Format: Layer, Start, End, Style, Name, MarginL, MarginR, MarginV, Effect, Text
Dialogue: 0,0:00:00.00,0:00:01.74,Default,,0000,0000,0000,,Nadležna tijela za zdravstvo
Dialogue: 0,0:00:01.74,0:00:04.93,Default,,0000,0000,0000,,odobrila su upotrebu cjepiva tvrtke \NModerna protiv bolesti COVID-19
Dialogue: 0,0:00:04.93,0:00:06.25,Default,,0000,0000,0000,,u Singapuru.
Dialogue: 0,0:00:06.25,0:00:08.08,Default,,0000,0000,0000,,Prva isporuka se očekuje
Dialogue: 0,0:00:08.08,0:00:09.02,Default,,0000,0000,0000,,sljedeći mjesec
Dialogue: 0,0:00:09.02,0:00:10.79,Default,,0000,0000,0000,,i postepeno će se primjenjivati
Dialogue: 0,0:00:10.79,0:00:12.68,Default,,0000,0000,0000,,na svima u dobi od 18 godina\Npa nadalje.
Dialogue: 0,0:00:12.68,0:00:13.93,Default,,0000,0000,0000,,Više o tome, Nisha Rahim:
Dialogue: 0,0:00:14.47,0:00:16.77,Default,,0000,0000,0000,,[Nisha Rahim] Prošlo je mjesec dana
Dialogue: 0,0:00:16.77,0:00:18.47,Default,,0000,0000,0000,,otkad je Singapuru isporučeno prvo
Dialogue: 0,0:00:18.47,0:00:20.82,Default,,0000,0000,0000,,cjepivo tvrtke Pfizer protiv\Nbolesti COVID-19.
Dialogue: 0,0:00:21.72,0:00:23.82,Default,,0000,0000,0000,,Ubrzo nakon toga,\Ndržava je pokrenula
Dialogue: 0,0:00:23.85,0:00:25.33,Default,,0000,0000,0000,,svoj program cijepljenja.
Dialogue: 0,0:00:25.35,0:00:27.70,Default,,0000,0000,0000,,Singapur je u srijedu \Nodobrio upotrebu
Dialogue: 0,0:00:27.70,0:00:30.06,Default,,0000,0000,0000,,cjepiva protiv bolesti COVID-19\Ntvrtke Moderna.
Dialogue: 0,0:00:30.26,0:00:32.42,Default,,0000,0000,0000,,Prva isporuka očekuje se
Dialogue: 0,0:00:32.42,0:00:33.75,Default,,0000,0000,0000,,tijekom sljedećeg mjeseca.
Dialogue: 0,0:00:33.77,0:00:35.49,Default,,0000,0000,0000,,Ovo cjepivo je drugo
Dialogue: 0,0:00:35.49,0:00:36.80,Default,,0000,0000,0000,,koje je odobrilo
Dialogue: 0,0:00:36.80,0:00:38.40,Default,,0000,0000,0000,,nadležno tijelo za zdravstvo
Dialogue: 0,0:00:38.40,0:00:40.42,Default,,0000,0000,0000,,i odbor stručnjaka
Dialogue: 0,0:00:40.42,0:00:42.31,Default,,0000,0000,0000,,za cijepiva protiv bolesti COVID-19.
Dialogue: 0,0:00:42.49,0:00:45.26,Default,,0000,0000,0000,,Ono ima visoku učinkovitost \Nod preko 94 %.
Dialogue: 0,0:00:45.26,0:00:48.17,Default,,0000,0000,0000,,Učinkovitost se temelji na podacima\Ntreće faze
Dialogue: 0,0:00:48.17,0:00:50.89,Default,,0000,0000,0000,,kliničkih ispitivanja, koje je\Nprovedeno na preko 30.000
Dialogue: 0,0:00:50.89,0:00:53.86,Default,,0000,0000,0000,,sudionika u dobi između \N18 i 95 godina.
Dialogue: 0,0:00:54.62,0:00:56.48,Default,,0000,0000,0000,,Režim cijepljenja\Ntvrtke Moderna
Dialogue: 0,0:00:56.48,0:00:59.07,Default,,0000,0000,0000,,zahtijeva primjenu dviju\Ndoza cjepiva u razmaku od
Dialogue: 0,0:00:59.07,0:01:00.20,Default,,0000,0000,0000,,28 dana.
Dialogue: 0,0:01:00.90,0:01:02.68,Default,,0000,0000,0000,,Za razliku od cjepiva\Ntvrtke Pfizer,
Dialogue: 0,0:01:02.68,0:01:04.26,Default,,0000,0000,0000,,koje je odobreno za osobe
Dialogue: 0,0:01:04.26,0:01:06.04,Default,,0000,0000,0000,,u dobi od 16 godina pa nadalje,
Dialogue: 0,0:01:06.04,0:01:08.50,Default,,0000,0000,0000,,cjepivo tvrtke Moderna odobreno\Nje za osobe od
Dialogue: 0,0:01:08.50,0:01:09.58,Default,,0000,0000,0000,,18 godina pa nadalje.
Dialogue: 0,0:01:09.58,0:01:10.98,Default,,0000,0000,0000,,Cjepivo ne bi smjele primiti
Dialogue: 0,0:01:11.03,0:01:12.68,Default,,0000,0000,0000,,trudnice,
Dialogue: 0,0:01:12.68,0:01:14.96,Default,,0000,0000,0000,,ozbiljno imunokomprimitirane\Nosobe
Dialogue: 0,0:01:14.96,0:01:16.44,Default,,0000,0000,0000,,i osobe s poviješću
Dialogue: 0,0:01:16.44,0:01:17.97,Default,,0000,0000,0000,,ozbiljnih alergija.
Dialogue: 0,0:01:17.97,0:01:19.21,Default,,0000,0000,0000,,Prema jednom stručnjaku,
Dialogue: 0,0:01:19.21,0:01:20.81,Default,,0000,0000,0000,,cjepivo tvrtke Moderna\Nslično je
Dialogue: 0,0:01:20.81,0:01:22.61,Default,,0000,0000,0000,,onome tvrke Pfizer/BioNTech \Nu pogledu
Dialogue: 0,0:01:22.61,0:01:23.78,Default,,0000,0000,0000,,profila i učinkovitosti.
Dialogue: 0,0:01:23.99,0:01:26.04,Default,,0000,0000,0000,,[Zamjenik direktora] Smatram da \Nnema velike
Dialogue: 0,0:01:26.04,0:01:27.87,Default,,0000,0000,0000,,razlike između ta dva cjepiva,
Dialogue: 0,0:01:27.92,0:01:29.98,Default,,0000,0000,0000,,ako gledate podatke kliničkih ispitivanja.
Dialogue: 0,0:01:30.27,0:01:32.26,Default,,0000,0000,0000,,Učinkovitost je skoro pa jednaka.
Dialogue: 0,0:01:32.26,0:01:34.68,Default,,0000,0000,0000,,U oba slučaja oko 95 %.
Dialogue: 0,0:01:34.68,0:01:36.37,Default,,0000,0000,0000,,Profil nuspojava je skoro
Dialogue: 0,0:01:36.37,0:01:37.44,Default,,0000,0000,0000,,pa isti.
Dialogue: 0,0:01:37.44,0:01:40.26,Default,,0000,0000,0000,,Tvrtka Moderna primjenjuje nešto veću
Dialogue: 0,0:01:40.26,0:01:41.50,Default,,0000,0000,0000,,dozu od tvrtke Pfizer:
Dialogue: 0,0:01:42.14,0:01:45.01,Default,,0000,0000,0000,,100 mcg u usporedbi s 30 mcg.
Dialogue: 0,0:01:45.47,0:01:47.25,Default,,0000,0000,0000,,[Nisha Rahim] Uvjeti skladištenja
Dialogue: 0,0:01:47.25,0:01:49.31,Default,,0000,0000,0000,,su različiti, cjepiva tvrtke Pfizer
Dialogue: 0,0:01:49.31,0:01:51.85,Default,,0000,0000,0000,,skladište se na -70 °C,
Dialogue: 0,0:01:52.03,0:01:55.04,Default,,0000,0000,0000,,a tvrtke Moderna na -20 °C.
Dialogue: 0,0:01:55.51,0:01:56.85,Default,,0000,0000,0000,,To neće biti problem
Dialogue: 0,0:01:56.85,0:01:59.02,Default,,0000,0000,0000,,jer Singapur ima \Nkapacitete za skladištenje
Dialogue: 0,0:01:59.02,0:01:59.94,Default,,0000,0000,0000,,oba cjepiva.
Dialogue: 0,0:01:59.94,0:02:01.76,Default,,0000,0000,0000,,Sada je bitno
Dialogue: 0,0:02:01.76,0:02:03.76,Default,,0000,0000,0000,,ima li dovoljno\Npripremljenih zaliha.
Dialogue: 0,0:02:03.96,0:02:06.36,Default,,0000,0000,0000,,[Zamjenik direktora] Najveća briga \Ntrenutno je,
Dialogue: 0,0:02:06.36,0:02:09.92,Default,,0000,0000,0000,,koje će cjepivo biti dostupno
Dialogue: 0,0:02:09.92,0:02:11.09,Default,,0000,0000,0000,,Singapuru.
Dialogue: 0,0:02:11.13,0:02:13.61,Default,,0000,0000,0000,,Doći će do\Nglobalnog manjka
Dialogue: 0,0:02:13.61,0:02:14.86,Default,,0000,0000,0000,,u proizvodnji
Dialogue: 0,0:02:14.86,0:02:16.65,Default,,0000,0000,0000,,jer potražnja upravo sada
Dialogue: 0,0:02:16.65,0:02:19.12,Default,,0000,0000,0000,,nadaleko nadmašuje\Nopskrbu.
Dialogue: 0,0:02:19.12,0:02:21.18,Default,,0000,0000,0000,,Stoga smatram da je za\Nstanovnike Singapura
Dialogue: 0,0:02:21.18,0:02:22.58,Default,,0000,0000,0000,,važnije pitanje
Dialogue: 0,0:02:22.58,0:02:24.54,Default,,0000,0000,0000,,„Djeluju li ta cjepiva?”
Dialogue: 0,0:02:24.54,0:02:25.72,Default,,0000,0000,0000,,Odgovor je „da”.
Dialogue: 0,0:02:25.72,0:02:27.66,Default,,0000,0000,0000,,„Jesu li sigurna?”, mislim da je odgovor
Dialogue: 0,0:02:27.66,0:02:28.47,Default,,0000,0000,0000,,„da".
Dialogue: 0,0:02:28.55,0:02:32.04,Default,,0000,0000,0000,,Praktično nema \Nprave razlike
Dialogue: 0,0:02:32.16,0:02:33.98,Default,,0000,0000,0000,,između ova dva cjepiva,
Dialogue: 0,0:02:33.98,0:02:37.27,Default,,0000,0000,0000,,tako da je pitanje u biti
Dialogue: 0,0:02:37.27,0:02:39.54,Default,,0000,0000,0000,,kojeg se Singapur može
Dialogue: 0,0:02:39.54,0:02:40.58,Default,,0000,0000,0000,,dokopati?
Dialogue: 0,0:02:40.62,0:02:41.75,Default,,0000,0000,0000,,[Nisha Rahim] Od utorka
Dialogue: 0,0:02:41.75,0:02:44.48,Default,,0000,0000,0000,,je više od 175.000 ljudi
Dialogue: 0,0:02:44.48,0:02:46.28,Default,,0000,0000,0000,,u Singapuru primilo
Dialogue: 0,0:02:46.28,0:02:48.69,Default,,0000,0000,0000,,prvu dozu cjepiva tvrtke Pfizer/BioNTech.
Dialogue: 0,0:02:48.69,0:02:50.77,Default,,0000,0000,0000,,Oko 6000 od njih je također
Dialogue: 0,0:02:50.77,0:02:52.48,Default,,0000,0000,0000,,primilo drugu dozu cjepiva.